Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 1, 2005
At a meeting with analysts and investors, Company provided ranges for both sales and earnings goals for the three-year period.
-
Jan 31, 2005
Next-generation stent system has been launched in 18 countries.
-
Jan 27, 2005
On February 1, Company will provide financial guidance for 2005, and financial goals for 2006 and 2007. Learn how to tune in.
-
Jan 20, 2005
A live webcast and replay of the January 25th session will be available. Learn how to tune in for the presentation.
-
Jan 19, 2005
Marks a major milestone for the Company and for the treatment of coronary artery disease.
-
Jan 17, 2005
Launch of TAXUS™ Liberté™ paclitaxel-eluting coronary stent system in 18 countries provides physicians state-of-the-art drug-eluting stent technology for the treatment of coronary artery disease.
-
Jan 10, 2005
The announcement was made by Jim Tobin, President and Chief Executive Officer, at the JPMorgan Healthcare Conference in San Francisco.
-
Jan 6, 2005
U.S. District Court in Delaware granted summary judgment of non-infringement in favor of Boston Scientific.
-
Jan 4, 2005
A live webcast and replay of the January 10th session will be available. Learn how to tune in for the presentation.
-
Dec 31, 2004
Jim Tobin, President and CEO, calls Company’s 2004 performance “nothing short of remarkable and speaks to a truly global effort."